Skip to main content

A rare ocular complication of septicemia: a case series report and literature review



Septicemia that leads to ocular involvement mostly presents as endophthalmitis or panophthalmitis. Contrarily, septicemia without intraocular involvement, known as hematogenous orbital cellulitis (HOC), involves only the orbit and is an extremely rare complication of septicemia and a rare type of orbital cellulitis.

Case presentation

Four male patients with septicemia presented with orbital involvement without intraocular infection were described in this study. They were 22 (case 1), 15 (case 2), 79 (case 3), and 30 (case 4) years old, with a mean age of 29.75 years. All patients were immunocompromised except for case 2. Cases 1 and 3 had a history of steroid use, whereas case 4 was in a post-chemotherapy myelosuppression phase. Septicemia in case 1 was community-acquired, cases 3 and 4 were hospital-acquired, and case 2 was secondary to acne squeezing. Blood cultures from cases 1, 2, and 3 were positive for Candida albicans, methicillin-resistant Staphylococcus aureus, and Klebsiella pneumoniae, respectively. Case 4 had negative cultures; however, next-generation sequencing reported the presence of Enterococcus faecalis and Rhizopus oryzae. Case 1 had right eye involvement, and both eyes were involved in the other three cases. According to Chandler’s classification, case 1 was type 2, case 2 was type 2 (OD) and type 4 (OS), and cases 3 and 4 were type 1 orbital infections. All patients had eyelids erythema, and cases 1 and 2 had mildly decreased visual acuity, proptosis, and painful and restricted ocular motility. Hospital stays ranged from 13 to 43 days (mean, 24 days). All patients received systemic antibiotic therapy based on drug sensitivity and next-generation sequencing results, in combination with multidisciplinary treatment, resulting in complete recovery of ocular and systemic signs and symptoms; no ocular surgical interventions were performed. Extraocular muscle palsy was the last symptom to resolve.


HOC is predominantly seen in immunocompromised individuals with a high proportion of hospital-acquired infections and positive cultures for pathogens. Infection control using systemic antibiotics targeted at the causative organism guarantees a favorable prognosis.

Peer Review reports


Orbital cellulitis (OC) is a common orbital disease that typically arises from the direct spread of nearby infection and is more prevalent in children than adults [1, 2]. Hematogenous orbital cellulitis (HOC), an extremely rare type of orbital cellulitis, is caused by infection spread from a distant source via blood transfer to the orbit without intraocular involvement, and is an uncommon ocular complication of septicemia that mostly presents as endophthalmitis or panophthalmitis. HOC has different pathogenic profiles and clinical manifestations than contiguous spreading OC; nevertheless, very few studies have been reported on this type of OC. Herein, we present four cases of HOC involving five rare causative organisms for OC.

Case presentation

Case 1

A 22-year-old man experienced cough, sticky sputum, and high temperature for 3 days and then developed right eyelid swelling, followed by right ear pus discharge and ocular pain. Intravenous amoxicillin was administered at a local clinic with no relief; therefore, he was referred to our emergency room and admitted to the Infectious Ward. Apart from a 14-year steroid medication history for non-infectious skin diseases, no other significant medical history was reported. On admission, he was malaise with a stiff neck and prominent breath sounds. Additionally, ophthalmologic examination (OE) revealed better visual acuity (VA) than finger counting (FC) at 1 m, fixed and protruding right eye with swollen and red eyelids, conjunctival infection and hemorrhage, sensitive pupillary reflex, but no lens and fundus abnormalities. The left eye was unremarkable. Lung computerized tomography (CT) revealed cavitated nodules in both lungs (Fig. 1A); orbital CT showed proptosis, infectious lesions in the upper and lateral sides of the retrobulbar orbit, mastoiditis, maxillary and ethmoid sinusitis, and right otitis (Fig. 1B, C). No orbital abscess was present, and according to Chandler’s classification of orbital infection, the patient had a type 2 infection [3]. Magnetic resonance imaging (MRI) could not be performed completely. Lumbar puncture (LP) revealed a high intracranial pressure (ICP) of 380 mmH2O with clear cerebrospinal fluid (CSF). Candida albicans (C. albicans) were isolated by culturing blood samples using the BacT/ALERT® 3D automated microbiological testing system (bio-Mérieux, France). Sputum and ear pus samples also yielded C. albicans, but CSF showed negative result. All samples were also cultured anaerobically using BacT/ALERT® FN anaerobic medium.The same culture methods were used for the next three cases.In addition to efforts for lowering ICP and phlegm treatment, intravenous meropenem (MEM) was administered for 14 days, followed by fluconazole (FCA) and moxifloxacin (MXF) for 12 and 8 days, respectively. No ocular invasive procedure was carried out. Table 1 lists the peak values of the inflammatory indicators during the patient’s hospitalization. Fifteen days after admission, when all signs and symptoms except eyelid swelling and 10° of esotropia resolved and the laboratory tests came back normal, the patient was discharged. The last follow-up visit at 4 months showed complete resolution of systemic and ocular infection signs, and the VA was 20/20 in both eyes. Table 1 shows the values of inflammatory indicators at discharge, and Table 2 summarizes the clinical overview of all four patients.

Fig. 1
figure 1

Lung and orbital CTs of case 1 (A) On admission, multiple cavernous nodules were detected in both lungs, mainly concentrated in the periphery of the lungs (yellow arrows). (B, C): Right eye protrusion with infection mainly located in the lateral (B) and superior(C) parts of the right orbit (red arrows)

Table 1 Inflammatory indicators of the four HOC cases
Table 2 Overview of the four HOC cases

Case 2

A 15-year-old boy developed a fever and headache 2 days after squeezing a pimple on his forehead. He was admitted to a local hospital with skin furuncle, septicemia, purulent meningitis, and bilateral OC, for which he was administered amoxicillin (AM), vancomycin (VAN), ceftazidime (CAZ), and linezolid (LZD); however, his high fever (> 39 °C) persisted. He was then transferred to our hospital’s infection unit. On admission, he had malaise and a VA of 20/25 in the right eye and 20/60 in the left eye. Both eyes showed eyelids erythema, tenderness, and conjunctival infection, and all these symptoms were more severe on the left side. OM was initially normal and intraocular infection was absent. The patient’s lung CT revealed several infectious lesions in both lungs and slight pleural effusion (Fig. 2D). Cranial MRI revealed several abscesses (Fig. 2C). LP revealed CSF turbidity with an ICP of 270 mmH2O. Staphylococcus aureus (SA) was isolated from blood and CSF samples two days later and antibiotic susceptibility testing was performed using the VITEK 2 Compact system (bio-Mérieux, France). It was identified as Methicillin-resistant Staphylococcus aureus (MRSA) by the Cefoxitin screening test and oxacillin MIC determination. On the third day, the boy developed a conjunctive purulent patch in his left eye with ptosis and proptosis of the left eye and limited abduction of both eyes. Ocular B-ultrasound revealed a left orbital abscess that was confirmed using orbital MRI, which further revealed bilateral maxillary sinusitis, sigmoid sinusitis, sphenoid sinusitis, and left mastoiditis (Fig. 2A,B). Prior to microbiological testing, the patient was administered piperacillin-tazobactam (TZP) for 2 days. Subsequent to the results of the microbiological testing, LZD and daptomycin (DAP) were administered for 23 and 12 days, respectively, in combination with supportive therapies, such as hepatoprotection and gastric protection, ICP reduction, expectorant administration, and nutritional support. The symptoms and signs resolved and the inflammatory indicators returned to normal after 43 days of hospital stay (Table 1) with mild redness and swelling of the eyelids and limited abduction of the left eye. Upon discharge, repeated CT of the lungs, orbit, and head revealed a significant reduction and resolution of the abscesses (Fig. 2E F,2G,2 H); however, the VA remained the same as that at admission. No surgical intervention was performed. The patient was followed up for 28 months. By the 3rd month, his VA had improved to 20/25 bilaterally, and the swelling in both eyelids had subsided. By the 14th month, his diplopia and left lateral rectus palsy had resolved completely (Table 2).

Fig. 2
figure 2

Orbital MRI, head MRI, and lung CT of case 2 (A, B, C, and D) were examined on early admission and (E, F, G, and H) were re-examined 50 days later before discharge. (D) Lung CT showing bilateral lung inflammation, which was more severe on the left side (green arrows). (C) Head MRI (T2, coronal) showing brain abscess formation (yellow arrows). (A,B) Orbit MRI (T2, coronal; T2, sagittal) showing bilateral orbital inflammation and abscess formation in the upper left orbit (red arrows). (E, F, G, and H) Follow-up MRIs and CTs showing that the inflammation and abscesses in the lungs, cerebrum, and orbits had mostly resolved before discharge

Case 3

A 79-year-old male was admitted to the Department of Ophthalmology for corticosteroid impulse therapy for thyroid-related ophthalmopathy (TAO). On admission, his VA was limited to FC because of bilateral exposure keratitis. The intraocular pressure (IOP) was 14 and 13 mmHg in the left and right eyes, respectively. The patient had a history of hypertension but was not taking any medication for it. The day after admission, both his eyelids were partially sutured for corneal protection. After hospitalization, he was administered 500 mg of intravenous methylprednisolone (MP) once daily for 5 days, which was tapered to 240 mg on the 6th day. On the evening of the 6th day, the patient developed a high fever (up to 40.3 °C) with cough, sputum, and coarse breath sounds. Lung CT showed scattered infectious lesions in both lungs and consolidation in the right lower lung (Fig. 3A). Blood and sputum were sent for culture prior to administering cefoxitin (CFX) intravenously. The next day, he developed redness and tenderness in both eyelids. Ocular B-scan revealed bilateral cataracts, vitreous opacities, and enlarged extraocular muscles (EOM) due to TAO (Fig. 3C,D); however, post-septal infection was not present.

Fig. 3
figure 3

Lung CT and ocular ultrasound of case 3 (A) showing scattered infectious lesions in both lungs and a large patchy consolidation in the right lower lung when the fever occurred (red arrow). (B) Decreased lung inflammation and less extensive consolidation in the right lower lung 1 week later (red arrow). (C, D) Bilateral enlarged extraocular muscles due to TAO (yellow arrow)

He was then transferred to the infection unit. The sputum smear showed numerous gram-negative bacilli; hence, the antibiotic was changed to imipenem (IMP). The next day, blood and sputum cultures were shown to be positive for Klebsiella. pneumoniae (K. pneumoniae), which is sensitive to IMP. Other treatments included expectorant administration, intravenous immunoglobulin and triglycerides for nutritional support, and ocular antibiotic eye drops and lubricating ointment. The infection gradually resolved, and he was discharged to a community hospital after 7 days of stay in the Infection ward. At discharge, both eyelids remained semi-sutured, the eyelid redness and swelling had subsided significantly, and the cough and sputum were relieved. Lung CT showed a reduction in inflammation and lesion consolidation (Fig. 3B). No recurrence of systemic or ocular infection was noted during the 7-month follow-up. At the last follow-up, there was no eyelid erythema or tenderness, no lagophthalmos, and the proptosis had regressed compared to that before steroid therapy. The ocular motility (OM) was restored, and IOP was 14 mmHg in both eyes. VA was limited to 20/50 in the right eye and 20/40 in the left due to bilateral corneal nebula formation and cataract.

Case 4

A 30-year-old male with an abnormal white blood cell (WBC) count (28.7 × 109/L) on physical examination (PE) was admitted to a local hospital and later diagnosed with acute myeloid leukemia (AML). His condition deteriorated quickly, with a high fever (up to 38.6 °C), pneumonia, splenomegaly, and pelvic, pleural, and pericardial effusion. Then, he was transferred to our facility for chemotherapy. Upon admission, a blood culture was performed and an anti-infective, anti-inflammatory, and diuretic therapy was initiated. Chemotherapy comprising the CIA regimen (cladribine 8.8 mg, days 1–3; idarubicin 20 mg, days 1–2 and 10 mg, day 3; cytarabine 170 mg, days 1–3 and 100 mg, days 4–5) was initiated on the 6th day of admission when the fever abated to 37.4 °C. The fever (38.6 °C) returned on the 2nd day of the chemotherapy course, and anal ulcers appeared on the 4th day. The patient experienced a critical myelosuppressive phase with persistent fever (37.3–38.9 °C) during and after the chemotherapy. Owing to negative blood culture results, a blood sample was sent for next-generation sequencing (NGS), which identified a mixed infection of Enterococcus faecalis (E. faecalis) and Rhizopus oryzae (R. oryzaei) 48 h later. NGS was performed twice to avoid interpretation errors.

On the 8th day after chemotherapy, the patient’s fever spiked to 39.9 °C, and he complained of redness and pain in both eyelids. A bedside OE revealed VA better than FC at 1 m in both eyes, with bilateral erythema, cutaneous ecchymosis, and eyelid tenderness. However, the conjunctiva, corneas, and lenses were unremarkable (Fig. 4A). Both fundi appeared myopic, with bleeding in the right retina without macular involvement. OM was unaffected, and no intraocular infection was noted. Bilateral auricular swelling and tenderness were present (Fig. 4B). As a result, bilateral pre-septal OC was considered, and topical ofloxacin ointment was applied. Due to the patient’s persistent septicemia and delayed pathogen results, his systemic antibiotic course was complicated. Initially, intravenous cefuroxime (CXM) was administered for 8 days, followed by intravenous MEM for 5 days, which was then switched to cefoperazone (CFP) for 12 days for targeting gram-negative microorganisms when the NGS identified E. faecalis. Next, intravenous VAN was given for 10 days, followed by tigecycline (TGC) for 6 days to target potential gram-positive organisms; prophylactic oral posaconazole (POS) was prescribed for 3 days, and intravenous voriconazole (VRC) for 6 days before NGS confirmed R. oryzae infection, and then, the medication was switched to intravenous liposomal amphotericin B (L-AMB) for 7 days with daily increments. Finally, the patient was prescribed oral POS before discharge, which he continued for approximately 5 months.

Fig. 4
figure 4

External eye and ear photographs when HOC occurred and blood counts during hospitalization of case 4. (A) Bilateral erythema of the eyelids (yellow arrows) and subcutaneous hemorrhage (red arrows) along with obvious tenderness. The symptoms on the left were milder than those on the right. (B) The auricle showed erythema and tenderness (white arrow). (C) White blood cell, neutrophil, and platelet count changes during the patient’s hospitalization along with important time points, including hospital admission and discharge, chemotherapy course, and HOC onset

The patient’s systemic infection resolved, and HOC resolved after 6 days of onset. He was discharged on the 14th day after chemotherapy after a 25-day hospital stay (Fig. 4C). During the 6-month follow-up, he reported occasional fevers but no HOC recurrence. The best corrected VA (BCVA) was 20/25 in both eyes, although retinal hemorrhage persisted in the right fundus. He is still being closely monitored and treated for AML by the Hematology Department.

Discussion and conclusions

OC is mostly caused by a direct spread of nearby infection and is more likely to occur in children than in adults; additionally, OC caused by septicemia is relatively rare [1, 4]. Ocular involvement in septicemia is mostly presented as endophthalmitis or panophthalmitis, and if OC is present, it is typically accompanied by panophthalmitis. HOC, which is an ocular complication of septicemia with only orbital involvement without intraocular infection, is extremely rare, and no case series on HOC have been reported previously.

For non-hematogenous OC or continuous spread OC, the most prevalent causative organisms are Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae, and odontogenic infections causing OC may also involve anaerobic bacteria [5]. The five causative pathogens identified in our case series are not commonly seen in OC. Case 2 acquired MRSA septicemia after squeezing a pimple. MRSA is the most prevalent pathogen causing skin infections in children; however, OC is a rare manifestation of MRSA infection. According to PH Blomquist’s study, only 1.3% of MRSA patients present with ocular involvement, and OC accounts for 19% of these cases [6]. Cases 1, 3, and 4 were infected with C. albicans, K. pneumoniae, E. faecalis, and R. oryzae, which are even rarer pathogens of OC compared to MRSA. To the best of our knowledge, only three cases of C. albicans-related OC have been published, including one case of panophthalmitis due to C. albicans septicemia and the other two due to non-hematogenous OC [7,8,9]. Additionally, no reports of OC caused by C. albicans septicemia without intraocular involvement have been published. K. pneumoniae is a highly invasive bacterium with the propensity to cause metastatic septic lesions with the eye being one of its target organs. In fact, K. pneumoniae is one of the most common causative organisms of nosocomial infections and endogenous endophthalmitis in China [10, 11]. The most prevalent form of K. pneumoniae-associated OC is K. pneumoniae panophthalmitis, including endogenous and exogenous panophthalmitis [12]. We noted eight published cases of K. pneumoniae-associated OC without intraocular involvement, and only two were due to hematogenous spread and both were post-septal OC [13, 14], which is different from our case who had pre-septal OC induced by hospital-acquired K. pneumoniae septicemia after glucocorticoids treatment. The prognosis of our case was much better compared to most ocular K. pneumoniae infections due to the absence of intraocular infection, though the BCVA of case 3 was limited to 20/40 and 20/50 because of TAO and cataracts.

Case 4 involved a combination infection caused by a bacterium and a fungus. Though his blood culture was negative, NGS identified E. faecalis and R. oryzae as the causative organisms. We found five cases of E. faecalis-associated OC reported in the literature, three of which were of endogenous panophthalmitis with intraocular infection, and the other two were of OC without intraocular involvement; however, as described by Biedner et al. in 1986, only one of these was due to septicemia, which was that of a female infant who presented with septicemia, ethmoiditis, and OC [15]. Another case of OC without intraocular involvement was that of a healthy 10-year-old Indian boy who developed OC from a contaminated hand after scratching his boils [16]. Another pathogen in case 4 was R. oryzae, a widespread saprophytic fungus that rarely affects healthy individuals, although it may cause infection in immunocompromised individuals and develop into mucormycosis. Invasive mucormycosis is an extremely aggressive fungal disease with a mortality rate of 22–59% [17, 18] and has become the third most common invasive fungal infection in adult patients with malignant hematologic diseases, such as in case 4 [19, 20]. Nearly 60% of mucormycosis is caused by R. oryzae, 90% of which are of the rhinio-orbital-cerebral mucormycosis (ROCM) type [21]. OC caused by R. oryzae usually presents as an ROCM phenotype with critical conditions and a dismal prognosis. Since case 4 only presented with pre-septal OC and auriculitis and did not show other typical ROCM manifestations, we speculate that the OC in case 4 might only be related to E. faecalis.

In our case series, the positivity rate of causative organisms was 100%, and the blood culture positive rate was 75% (3/4), which is clearly higher than that of non-bloodborne OC, which is approximately 2–7.9% [22, 23]. These findings are expected since the pathogens of HOC are transported via the bloodstream. Collecting blood or other samples for culture before administration of antibiotics may increase the positivity rate. When routine cultures are negative, NGS is recommended to identify the causative microorganism, as was done in case 4. NGS is a high-throughput sequencing method for massive parallel sequencing that uses targeted amplicon sequencing or microbial whole genome sequencing strategies to sequence millions of small DNA fragments simultaneously. NGS does not require sequence-specific amplification and is highly effective in diagnosing systemic or ocular infectious diseases of unknown origin or in patients with suspected infection who have negative culture results [24, 25]. NGS provides faster results, especially when the pathogen is likely to be a fungus, as most pathogenic fungi take 48–72 h and sometimes 2–4 weeks to grow. Contrarily, NGS can provide results in 48 h regardless of whether the organism is a bacteria, fungus, or parasite.

Patients with HOC are usually at high risk of other diseases due to septicemia. Early identification of pathogens and administration of targeted antibiotics to control systemic and ocular infections swiftly are essential for saving the patient’s life and vision. Case 4 had AML and thus belonged to a high-risk group of nosocomial fungal infections. Despite prophylactic administration of POS on admission, he experienced persistent fever during his hospitalization, especially in the post-chemo myelosuppression phase. When R. oryzae was identified by NGS, the antifungal medication was switched to L-AMB, and the infection was predictably controlled. Therefore, NGS is recommended to identify pathogens when patients are in critical condition and have negative culture or a poor response to empirical therapies. However, it should be acknowledged that the high cost of NGS testing, non-coverage by medical insurance, and bias in the interpretation of its results limit its widespread clinical use [24].

The vulnerable groups and the pathogenic spectrum of HOC differ from non-hematogenous OC, which often affects children and occasionally adults, usually immunocompetent, whereas the patients’ age in HOC varies widely, ranging from adolescents to the elderly, mainly affecting immunocompromised individuals, and the infection may be nosocomial, all of which share some similarities with endogenous endophthalmitis [26, 27]. In our case series, three of the four patients were immunosuppressed. Cases 1 and 3 were associated with steroid use, while case 4 had AML and underwent chemotherapy. The causative microorganisms in these three patients were C. albicans, K. pneumoniae, E. faecalis, and R. oryzae., all of which are opportunistic pathogens and causative agents of nosocomial infections and have low chances of causing infection in immunocompetent individuals, thus seldom causing non-hematogenous OC.

The ocular manifestations of HOC are similar to those of non-hematologic OC and include eyelids erythema and periorbital tenderness; additionally, proptosis and restricted and painful OM is seen when the post-septal orbit is involved and is sometimes accompanied by decreased visual acuity. Patients with HOC may present with severe general conditions, such as persistent high fever, markedly elevated inflammatory indicators, and longer hospital stays. Three of the four HOC patients had a temperature > 39 ℃, with case 3 developing a maximum temperature of 40.3 ℃. WBC, neutrophils, and other inflammatory markers, such as c-reactive protein, erythrocyte sedimentation rate, and procalcitonin levels were significantly elevated in all cases. Among them, the WBC count of case 4 was mainly determined by his underlying disease and treatment rather than inflammation. The hospitalization durations of our cases ranged from 13 to 43 days, with an average of 24 days, much longer than that of non-blood-borne OC [1]. Septicemia is common in both HOC and non-hematogenous OC; in HOC, septicemia is the cause, whereas in non-hematogenous OC, septicemia is its complication. Both HOC and non-hematogenous OC have a high proportion of intracranial extension, with the former associated with microorganisms entering via hematogenous spread and the latter typically originating from direct infection extension from nearby structures. Typical clinical manifestations of brain abscess include headache, fever, and focal neurological deficits, but < 50% of cases have all triads [28]. Herein, two of the four patients had CNS involvement, as indicated by headache, neck stiffness, intracranial hypertension, imaging findings, and CSF test results. Sometimes microbes may be isolated from CSF samples, as seen in case 2.

HOC treatments are divided into three categories: anti-infection, systemic support, and ocular treatments, and infection control is key in its management. Due to the markedly different spectrum of the causative organisms, the experience with non-hematogenous OC may not be applicable for HOC, which is commonly caused by opportunistic pathogens and can be hospital-acquired, necessitating expert consultation and higher-level antibiotics, such as VAN; third- and fourth-generation cephalosporins; carbapenems; newly synthesized antibiotics; such as LZD, DAP, TGC; and a combination of antifungal agents in some cases [29]. Antibiotic regimens should be dynamically adjusted to the patient’s response, such as temperature, inflammatory factor levels, and culture results of the causative organism. HOC patients usually present with systemic diseases or an immunosuppressed state and are more likely to be in critical condition, thus requiring multidisciplinary and supportive treatments. The management of case 1, for example, required the involvement of the Emergency, Respiratory, Dermatology, Ophthalmology, Otorhinolaryngology, Infection, and Neurology Departments. As for the ocular treatments in OC, the requirement for surgical intervention varies from case to case. No surgical intervention is needed for pre-septal OC; however, in post-septal OC, the need for surgical intervention depends on the presence of an abscess and response to antibiotic therapy. When compared with non-hematogenous OC, which has a higher rate of abscess formation than HOC, HOC is less likely to lead to an orbital abscess and responds well to antibiotics, lowering the chance of surgical intervention [1, 30]. Besides ocular severity and response to anti-infective treatments, other factors affecting surgical intervention include imaging findings and the availability of orbital surgeons, otolaryngologists, and, in the case of pediatric patients, anesthesiologists [1, 30]. In our case series, only case 2 had an orbital abscess; nevertheless, the patient responded well to antibiotic treatment and showed gradual resolution of the abscess; thus, surgical intervention was spared. Other ocular treatments for OC included eye drops or ointments and treatment for comorbid ocular conditions unrelated to OC, such as TAO in case 3 and retinal hemorrhage in case 4.

Patients with OC suffer from restricted and painful eye movement, indicating the involvement of EOMs. In contiguously spreading OC, the medial rectus, which is closest to the sinuses, is usually the first and the most frequently involved EOM, [30, 31] while in HOC, it appears to be less frequently involved due to the different infection routes. In HOC, the EOM palsy may be induced by intracranial conditions affecting the innervating nerves. The adductor nerve has the longest pathway at the base of the skull and is most likely to be affected by intracranial lesions. Cases 1 and 2 were both of post-septal OC with intracranial hypertension, the lateral and superior recti were mainly affected, and the lateral rectus palsy was the last to recover; case 2 required 18 months for recovery.

Despite the relatively aggressive systemic condition, the ocular prognosis of HOC seems satisfactory. As for our case series, there are three main reasons for the good outcome. First, we excluded OC associated with panophthalmitis. No patients had any intraocular infection, thus presenting with a good VA at admission and post-treatment. Second, three of the four cases had no orbital abscess, with little impact on the eyeball and optic nerve, guaranteeing a good prognosis. Third, a satisfactory anti-infective effect on the OC resulted from the high culture-positive rate and the pathogen-targeted antibiotic regimen.

In conclusion, this is the first case series report of HOC that is free of intraocular involvement. HOC is a rare ocular complication of septicemia that can affect people of all ages, especially immunosuppressed adults. Compared to non-hematogenous OC, HOC has a more severe systemic presentation but a relatively milder ocular manifestation. Blood cultures are highly positive and NGS testing is recommended if routine cultures are negative. The causative microorganisms of HOC are predominantly opportunistic pathogens, possibly hospital-acquired and fungal. Infection control with systemic antibiotics based on the causative organism in combination with multidisciplinary management guarantees a favorable prognosis. This study will provide some guidance for future diagnosis and treatment of the ocular complications of septicemia.

Data Availability

All data generated or analysed during this study are included in this published article.





Acute myeloid leukemia


Best corrected visual acuity








Central Nervous System


C-reactive protein


Cerebrospinal fluid


Computerized tomography






Extraocular muscles


Erythrocyte Sedimentation Rate


Finger counting






Hematogenous orbital cellulitis


Intracranial pressure




Intraocular pressure


Liposomal amphotericin B


Lumbar puncture








Magnetic Resonance Imaging


Methicillin-resistant Staphylococcus aureus


Microbial whole genome sequencing




Next-generation sequencing


Orbital cellulitis


Ophthalmologic examination


Ocular motility




Physical examination




Rhinio-orbital-cerebral mucormycosis


Thyroid-associated ophthalmopathy


Targeted amplicon sequencing






Visual acuity






White blood cell


  1. Tsirouki T, Dastiridou AI, Ibánez Flores N, Cerpa JC, Moschos MM, Brazitikos P, Androudi S. Orbital cellulitis. Surv Ophthalmol. 2018;63(4):534–53.

    Article  PubMed  Google Scholar 

  2. Collazos J, de la Fuente B, García A et al. Cellulitis in adult patients: a large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PloS one 2018 13(9), e0204036.

  3. Chandler JR, Langenbrunner DJ, Stevens ER. The pathogenesis of orbital complications in acute sinusitis. Laryngoscope. 1970;80:1414–28.

    Article  CAS  PubMed  Google Scholar 

  4. Stead TG, Retana A, Houck J, Sleigh BC, Ganti L. Preseptal and Postseptal Orbital Cellulitis of Odontogenic Origin Cureus, 2019,11(7), e5087.

  5. Brook I. Microbiology and antimicrobial treatment of orbital and intracranial complications of sinusitis in children and their management. Int J Pediatr Otorhinolaryngol. 2009;73(9):1183–6.

    Article  PubMed  Google Scholar 

  6. Blomquist PH. Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an american Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:322–45.

    PubMed  PubMed Central  Google Scholar 

  7. Kwak OS, Kang MI, Kim JB, Kim MW, Kim Y. K. A rare case of facial Candida albicans cellulitis in an uncontrolled diabetic patient. Mycoses. 2009;52(4):379–81.

    Article  PubMed  Google Scholar 

  8. Manfredi R, Sabbatani S. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole. Scandinavian J Infect Dis 2006,38(10), 950–1.

  9. Motukupally SR, Nanapur VR, Chathoth KN, et al. Ocular infections caused by Candida species: type of species, in vitro susceptibility and treatment outcome. Ind J Med Microbiol. 2015;33(4):538–46.

    Article  CAS  Google Scholar 

  10. Gan LY, Ye JJ, Zhou HY, Min HY, Zheng L. Microbial spectrum and risk factors of endogenous endophthalmitis in a tertiary center of Northern China. Int J Ophthalmol. 2022;15(10):1676–82.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Danielescu C, Anton N, Stanca HT, Munteanu M. Endogenous endophthalmitis: a review of Case Series published between 2011 and 2020. J Ophthalmol, 2020, 8869590.

  12. Ghiam BK, Israelsen P, Wang A, Grob S, Esfahani MR. Klebsiella pneumoniae endogenous endophthalmitis presenting as orbital cellulitis. GMS Ophthalmol cases. 2019;9:Doc30.

    PubMed  PubMed Central  Google Scholar 

  13. Yang SJ, Park SY, Lee YJ, et al. Klebsiella pneumoniae orbital cellulitis with extensive vascular occlusions in a patient with type 2 diabetes. Korean J Intern Med. 2010;25(1):114–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Yen CH, Wu SY, Liao YL. Klebsiella pneumoniae Orbital Cellulitis: clinical manifestations and outcomes in a Tertiary Medical Center in Taiwan. J Ophthalmol, 2018, 4237573.

  15. Biedner BZ, Marmur U, Yassur Y. Streptococcus faecalis orbital cellulitis. Ann Ophthalmol. 1986;18(5):194–5.

    CAS  PubMed  Google Scholar 

  16. Kohli P, Ichhpujani P, Bansal RK, Kumar S. A rare case of Enterococcus faecalis-induced orbital cellulitis and myositis. Indian J Ophthalmol. 2016;64(8):609–11.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Bassetti M, Bouza E. Invasive mould infections in the ICU setting: complexities and solutions. J Antimicrob Chemother. 2017;72(suppl1):i39–i47.

    Article  CAS  PubMed  Google Scholar 

  18. Francis JR, Villanueva P, Bryant P, Blyth CC. Mucormycosis in children: review and recommendations for management. J Pediatr Infect Dis Soc. 2018;7(2):159–64.

    Article  Google Scholar 

  19. Kriengkauykiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol. 2011;3:175–91.

    PubMed  PubMed Central  Google Scholar 

  20. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect diseases: official publication Infect Dis Soc Am. 2005;41(5):634–53.

    Article  Google Scholar 

  21. Sugar AM. Agents of mucormycosis and related species. Mandell Douglas & Bennetts Principles & Practice of Infectious Diseases; 2005.

  22. Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis. 1999;29(6):1483–8.

    Article  CAS  PubMed  Google Scholar 

  23. Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect. 2012;64(2):148–55.

    Article  PubMed  Google Scholar 

  24. Ma L, Jakobiec FA, Dryja TP. Review of Next-Generation sequencing (NGS): applications to the diagnosis of Ocular Infectious Diseases. Semin Ophthalmol. 2019;34(4):223–31.

    Article  CAS  PubMed  Google Scholar 

  25. Deshmukh D, Joseph J, Chakrabarti M et al. New insights into culture negative endophthalmitis by unbiased next generation sequencing. Sci Rep 2019, 9(1), 844.

  26. Gajdzis M, Figuła K, Kamińska J, Kaczmarek R. Endogenous endophthalmitis-the clinical significance of the primary source of infection. J Clin Med 2022,11(5), 1183.

  27. Qi M, He L, Zheng P, Shi X. Clinical features and mortality of endogenous panophthalmitis in China: a six-year study. Semin Ophthalmol. 2022;37(2):208–14.

    Article  PubMed  Google Scholar 

  28. Menon S, Bharadwaj R, Chowdhary A, Kaundinya DV, Palande DA. Current epidemiology of intracranial abscesses: a prospective 5 year study. J Med Microbiol. 2008;57(Pt 10):1259–68.

    Article  PubMed  Google Scholar 

  29. Chaudhry IA, Shamsi FA, Elzaridi E, et al. Outcome of treated orbital cellulitis in a tertiary eye care center in the middle East. Ophthalmology. 2007;114(2):345–54.

    Article  PubMed  Google Scholar 

  30. Lee S, Yen MT. Management of preseptal and orbital cellulitis. Saudi J Ophthalmol : official J Saudi Ophthalmological Soc 2011,25(1), 21–9.

  31. Hegde R, Sundar G. Orbital cellulitis- a review. TNOA J Ophthalmic Sci Res. 2017;55(3):211–9.

    Article  Google Scholar 

Download references


The authors would like to thank TopEdit ( for its linguistic assistance during the preparation of this manuscript.


The project is supported by Scientific Research Fund of Zhejiang Provincial Education Department, Y202147619.

Author information

Authors and Affiliations



Tang Xu-yuan designed the study, reviewed the literature,drafted the manuscript. Li Hui-yan was responsible for the revision of the manuscript. Both authors issued final approval for the version to be submitted.

Corresponding author

Correspondence to Li Hui-yan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

Ethics approval had been obtained from the Ethics Committee of the First Affiliated Hospital of Zhejiang University,School of Medicine, and all methods were performed in accordance with the relevant guidelines and regulations.

Consent to participate

Informed consents were obtained from all subjects and/or their legal guardians for the study .

Consent for publication

Written Informed consent statements were obtained from all study participants for publication of identifiable information/ images in open access journal.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu-yuan, T., Hui-yan, L. A rare ocular complication of septicemia: a case series report and literature review. BMC Infect Dis 23, 522 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: